Actively Recruiting
Extended 10-Year Follow-Up Study Comparing Two Transvaginal Mesh Procedures for Pelvic Organ Prolapse in Women
Led by Peking Union Medical College Hospital · Updated on 2023-07-11
336
Participants Needed
11
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the long-term success and complications of two types of transvaginal mesh surgeries for women with advanced pelvic organ prolapse POP stages III-IV. This observational study follows women who previously participated in a randomized controlled trial comparing a self-cut titanium-coated polypropylene mesh procedure with a mesh-kit procedure. The goal is to assess the effectiveness, safety, and cost differences between these two surgical methods over a period of up to 10 years after surgery. The study involves no new treatments but continues to monitor the women who had either the self-cut mesh surgery, which uses a single piece of mesh cut during surgery, or the mesh-kit surgery, which uses a pre-packaged titanium-coated mesh kit. Both procedures may include transvaginal hysterectomy if needed. Participants are encouraged to take part in annual examinations and telephone surveys to provide updates on their health and surgical outcomes. Participants will undergo yearly check-ups and telephone interviews to assess anatomical outcomes, symptom improvements, complications, and quality-of-life changes using various questionnaires up to 10 years post-operation. The main focus is on the composite success rate of the procedures over the long term. Safety and complication rates will be closely monitored throughout the study period to better understand the long-term effects of these surgeries.
CONDITIONS
Brief Title
Long-term Success Rate of Transvaginal Mesh for the Treatment of Pelvic Organ Prolapse: The Extended RCT Study
Research Team
L
Lan Zhu
J
Juan Chen
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here